Imatinib mesylate (STI571) decreases the vascular endothelial growth factor plasma concentration in patients with chronic myeloid leukemia [PDF]
Ludovic Legros
openalex +1 more source
QbD-based co-loading of paclitaxel and imatinib mesylate by protamine-coated PLGA nanoparticles effective on breast cancer cells. [PDF]
Laxane N, Yadav KS.
europepmc +1 more source
Complete laparoscopic wedge resection of a giant locally advanced gastric GIST with near pathological complete response after preoperative treatment with imatinib mesylate: A case report. [PDF]
Guo H+5 more
europepmc +1 more source
Imatinib Mesylate Efficiently Achieves Therapeutic Intratumor Concentrations in Vivo but Has Limited Activity in a Xenograft Model of Small Cell Lung Cancer [PDF]
Nicholas C. Wolff+4 more
openalex +1 more source
Malignant rectal GIST managed with chemotherapy (Imatinib Mesylate): A case report and a comprehensive review. [PDF]
Bhusal A+9 more
europepmc +1 more source
Combined Therapy of ATRA and Imatinib Mesylate Decreases BCR-ABL and ABCB1/MDR1 Expression Through Cellular Differentiation in a Chronic Myeloid Leukemia Model. [PDF]
Pinto CA+6 more
europepmc +1 more source
Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia [PDF]
Carlos E. Bueso‐Ramos+7 more
openalex +1 more source
Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis. [PDF]
Jimenez, Sergio A., Rosenbloom, Joel
core +1 more source
MiR-125a-3p and MiR-320b Differentially Expressed in Patients with Chronic Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem Cell Transplantation and Imatinib Mesylate. [PDF]
Martins JRB+7 more
europepmc +1 more source